Patient biomarker monitoring with outcomes to monitor overall healthcare delivery

US12100496B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12100496-B2
Application numberUS-202117156282-A
CountryUS
Kind codeB2
Filing dateJan 22, 2021
Priority dateJan 22, 2021
Publication dateSep 24, 2024
Grant dateSep 24, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Examples herein may include a computer-implemented method for providing outcome tracking of a plurality of patients, which may include generating a respective expected patient biomarker dataset for each of the plurality of patients, wherein the expected patient biomarker dataset may represent the expected values of a patient biomarker over the duration of the patient's recovery. The computer implementing method may include receiving respective actual patient biomarker data from respective patient sensor systems for each of the plurality of patients. The method may include aggregating the respective expected patient biomarker dataset and the respective actual patient biomarker data for each of the plurality of patients. The method may include determining differences between the respective expected patient biomarker data and the respective actual patient biomarker data. The method may include generating a treatment notification based on the differences.

First claim

Opening claim text (preview).

We claim: 1. A surgical hub for outcome tracking of a plurality of patients, comprising: a processor; and a memory coupled to the processor, the memory storing instructions, that when executed by the processor, cause the surgical hub to: control, via a plurality of first control signals, a plurality of surgical devices; generate a respective expected patient biomarker dataset for each of the plurality of patients, wherein the expected patient biomarker dataset represents the expected values of a patient biomarker over the duration of the patient's recovery; receive respective actual patient biomarker data from respective patient sensor systems for each of the plurality of patients; aggregate the respective expected patient biomarker dataset and the respective actual patient biomarker data for each of the plurality of patients; determine differences between the aggregated respective expected patient biomarker data and the aggregated respective actual patient biomarker data for each of the plurality of patients; generate a treatment notification based on the differences; output the differences to a facility analytics system; receive an updated control program from the facility analytics system based on the differences; and update the control of the plurality of surgical devices, via a plurality of second control signals, based on the updated control program. 2. The surgical hub of claim 1 , wherein the aggregated differences between the respected expected patient biomarker data and the respective actual patient biomarker data at any given time are for the same time in the patient's recovery. 3. The surgical hub of claim 1 , wherein the expected patient biomarker data is a set of values in a recovery timeline. 4. The surgical hub of claim 1 , wherein the treatment notification is a unique notification tailored for a specific group of patients. 5. The surgical hub of claim 1 , wherein the aggregated respective expected patient biomarker data and the aggregated respective actual patient biomarker data is by department or surgeon. 6. The surgical hub of claim 1 , wherein the aggregated respective expected patient biomarker data and the aggregated respective actual patient biomarker data is by procedure configuration, surgical instrument mix, complication type, re-admission rates, days of treatment, or time to intervention. 7. The surgical hub of claim 1 , wherein the treatment notification provides insights to follow-up metrics, facility of care, compliance, and intervention accuracies. 8. A method associated with a surgical hub for providing outcome tracking of a plurality of patients, comprising: controlling, via a plurality of first control signals, a plurality of surgical devices; generating a respective expected patient biomarker dataset for each of the plurality of patients, wherein the expected patient biomarker dataset represents the expected values of a patient biomarker over the duration of the patient's recovery; receiving respective actual patient biomarker data from respective patient sensor systems for each of the plurality of patients; aggregating the respective expected patient biomarker dataset and the respective actual patient biomarker data for each of the plurality of patients; determining differences between the respective expected patient biomarker data and the respective actual patient biomarker data; generating a treatment notification based on the differences; outputting the differences to a facility analytics system; receiving an updated control program from the facility analytics system based on the differences; and updating the control of the plurality of surgical devices, via a plurality of second control signals, based on the updated control program. 9. The method of claim 8 , wherein the differences between the aggregated respective expected patient biomarker data and the aggregated respective actual patient biomarker data at any given time are for the same time in the patient's recovery. 10. The method of claim 8 , wherein the expected patient biomarker data is a set of values in a recovery timeline. 11. The method of claim 8 , wherein the treatment notification is a unique notification tailored for a specific group of patients. 12. The method of claim 8 , wherein the aggregated respective expected patient biomarker data and the aggregated respective actual patient biomarker data is by department or surgeon. 13. The method of claim 8 , wherein the aggregated respective expected patient biomarker data and the aggregated respective actual patient biomarker data is by procedure configuration, surgical instrument mix, complication type, re-admission rates, days of treatment, or time to intervention. 14. The method of claim 8 , wherein the treatment notification provides insights to follow-up metrics, facility of care, compliance, and intervention accuracies. 15. A facility analytics system for outcome tracking of a plurality of patients, comprising: a processor; and a memory coupled to the processor, the memory storing instructions, that when executed by the processor, cause the facility analytics system to: establish communication with a surgical hub; receive a treatment notification from the surgical hub, wherein the treatment notification is based on differences of aggregated respective expected patient biomarker data and aggregated respective actual patient biomarker data for a plurality of patients; perform facility analytics based on the differences of the aggregated respective expected patient biomarker data and the aggregated respective actual patient biomarker data for the plurality of patients; generate an updated control program based on the facility analytics performed; and send the updated control program to the surgical hub to control the surgical hub. 16. The facility analytics system of claim 15 , wherein the differences between the aggregated respective expected patient biomarker data and the aggregated respective actual patient biomarker data at any given time are for the same time in the patient's recovery. 17. The facility analytics system of claim 15 , wherein the expected patient biomarker data is a set of values in a recovery timeline. 18. The facility analytics system of claim 15 , wherein the aggregated respective expected patient biomarker data and the aggregated respective actual patient biomarker data is by department or surgeon. 19. The facility analytics system of claim 15 , wherein the aggregated respective expected patient biomarker data and the aggregated respective actual patient biomarker data is by procedure configuration, surgical instrument mix, complication type, re-admission rates, days of treatment, or time to intervention. 20. The facility analytics system of claim 15 , wherein the treatment notification provides insights to follow-up metrics, facility of care, compliance, and intervention accuracies.

Assignees

Inventors

Classifications

  • ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring · CPC title

  • for patient-specific data, e.g. for electronic patient records · CPC title

  • relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture · CPC title

  • G16H20/00Primary

    ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance · CPC title

  • G16H50/70Primary

    for mining of medical data, e.g. analysing previous cases of other patients · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12100496B2 cover?
Examples herein may include a computer-implemented method for providing outcome tracking of a plurality of patients, which may include generating a respective expected patient biomarker dataset for each of the plurality of patients, wherein the expected patient biomarker dataset may represent the expected values of a patient biomarker over the duration of the patient's recovery. The computer im…
Who is the assignee on this patent?
Cilag Gmbh Int
What technology area does this patent fall under?
Primary CPC classification G16H20/00. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).